PHARMA NORD ApS: Financial statements 2025
CVR: 67303016
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PHARMA NORD ApS (CVR 67303016) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 518,005,000 and a net result of DKK 26,711,000 compared with DKK 32,254,000 the year before. That is an increase of 6.4% compared with the year before. The profit margin was 5.2%. Equity in the 2025 report amounted to DKK 181,417,000. The solvency ratio was 38.3%. The company had 473 employees in the financial year.
- Revenue
- DKK 518,005,000
- Gross Profit
- DKK 186,308,000
- Profit/Loss
- DKK 26,711,000
- Equity
- DKK 181,417,000
- Total Assets
- DKK 473,514,000
- Employees
- 473
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 518 mio. | 186.3 mio. | 26.7 mio. | 181.4 mio. | 473 |
| 2024 | 486.7 mio. | 180.3 mio. | 32.3 mio. | 143.3 mio. | 440 |
| 2023 | 447.4 mio. | 147.6 mio. | 23.3 mio. | 160.6 mio. | 416 |
| 2022 | 439.4 mio. | 187.5 mio. | 35.3 mio. | 183 mio. | 425 |
| 2021 | 470.2 mio. | 221 mio. | 58 mio. | 199.3 mio. | 420 |
Official annual report
How creditworthy is PHARMA NORD ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PHARMA NORD ApS has published its annual report for 2024. Revenue came to DKK 486,691,000, and the net result was DKK 32,254,000.
As of May 30, 2025, Sven Moesgaard has left the board of directors of PHARMA NORD ApS.
About PHARMA NORD ApS
PHARMA NORD ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 1981. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named DANMARKS HELSEKOST DISTRIBUTION ApS. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO I ApS and PharmCo III ApS. The company has 298 employees (2026). In 2025, the company reported revenue of DKK 518,005,000 and a net result of DKK 26,711,000 compared with DKK 32,254,000 the year before. Equity in the 2025 report amounted to DKK 181,417,000.